NasdaqCM:ESTA
NasdaqCM:ESTAMedical Equipment

A Look At Establishment Labs Holdings (ESTA) Valuation After Recent Share Price Volatility

With no single headline catalyst today, Establishment Labs Holdings (ESTA) is drawing attention after a mixed share performance, including a negative return over the past month but a strong gain across the past 3 months. See our latest analysis for Establishment Labs Holdings. That softer 30 day share price return of 10.18% comes after a 45.18% gain over the past 90 days and a 1 year total shareholder return of 96.47%. Recent momentum therefore looks more like a breather than a reversal when...
NYSE:BHC
NYSE:BHCPharmaceuticals

A Look At Bausch Health (BHC) Valuation After Reaffirmed 2025 Guidance Ahead Of Healthcare Conference

Bausch Health Companies (BHC) recently reaffirmed its full year 2025 guidance at the higher end of its previously announced range, excluding Bausch + Lomb, ahead of its appearance at the J.P. Morgan Healthcare Conference. See our latest analysis for Bausch Health Companies. The reaffirmed 2025 guidance comes after a period where the share price has shown stronger short term momentum, with a 90 day share price return of 24.58%. In contrast, the 5 year total shareholder return of a 72.75%...
NYSE:RTX
NYSE:RTXAerospace & Defense

How Investors Are Reacting To RTX (RTX) Curbing Dividends And Buybacks Under Trump’s New Defense Order

President Donald Trump recently signed an executive order barring large defense contractors, including RTX, from paying dividends and conducting stock buybacks until they deliver superior products on time and on budget, while also tightening rules around executive compensation tied to short‑term financial metrics. The order is especially significant for RTX, which was publicly criticized as the least responsive to government needs and the most aggressive in returning cash to shareholders,...